MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quantifying the value of multimodal MRI in outcomes prediction for STN DBS in PD

J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

Meeting: 2023 International Congress

Abstract Number: 1741

Keywords: Deep brain stimulation (DBS), Functional magnetic resonance imaging(fMRI), Parkinson’s

Category: Surgical Therapy: Parkinson's Disease

Objective: To compare the predictive value for motor outcomes of multimodal MRI to clinical predictors alone in STN DBS for PD.

Background: STN DBS is an effective treatment for the motor symptoms of PD, yet outcomes remain highly variable. Currently, pre-surgical levodopa response provides the most established prediction of clinical outcome, although its predictive power varies greatly across studies. MRI-based methods including resting state functional connectivity (FC), subcortical and cortical volumetrics, and DTI-based structural connectivity (SC) independently predict DBS outcomes, while a comprehensive model integrating these methods has not yet been developed.

Method: We included 61 participants who had multimodal MRI prior to STN DBS for PD and who had adequate clinical data before and after DBS, as well as good quality volumetric, DTI, and rs-fcMRI data. We applied clinical and MRI-based predictors from published studies including thalamic and ventricular volumes, FC and SC connectivity between STN and GPI, VL thalamus, and motor cortex. Regularized linear regression using the least absolute shrinkage and selection operator (LASSO) and leave-one-out cross-validation was used for model construction and factor selection, optimized to RMSE to avoid overfitting with addition of more variables. The primary outcome was percent change in UPDRS-III from the initial preoperative OFF-medication examination to the average OFF-medication, ON-stimulation score over the first year after DBS.

Results: The “traditional” model, constrained to only clinical predictors (including levodopa response, age, sex, handedness, LEDD, preoperative UPDRS-III) was modestly predictive of motor improvement (R2 = 0.29, RMSE = 14.9. In comparison, the total model, which included FC, SC, volumetric, and clinical predictors more strongly predicted motor improvement (R2 = 0.55, RMSE = 13.6). Factors included in the optimized model included STN-GPI FC, GPI-VL thalamus SC, VL thalamus-motor cortex SC, ventricular volume, age, preoperative UPDRS-III, and levodopa responsiveness.

Conclusion: Multimodal MRI greatly outperforms levodopa responsiveness alone in prediction of motor outcomes for STN DBS in PD. Addition of cognitive and psychiatric features both as predictors and as outcomes may further enhance the predictive power and clinical utility of this approach.

To cite this abstract in AMA style:

J. Younce, S. Norris, J. Perlmutter. Quantifying the value of multimodal MRI in outcomes prediction for STN DBS in PD [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/quantifying-the-value-of-multimodal-mri-in-outcomes-prediction-for-stn-dbs-in-pd/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quantifying-the-value-of-multimodal-mri-in-outcomes-prediction-for-stn-dbs-in-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley